KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Jazz Pharmaceuticals (JAZZ) Return on Equity (2016 - 2025)

Jazz Pharmaceuticals has reported Return on Equity over the past 15 years, most recently at 0.06% for Q4 2025.

  • Quarterly results put Return on Equity at 0.06% for Q4 2025, down 20.0% from a year ago — trailing twelve months through Dec 2025 was 0.06% (down 20.0% YoY), and the annual figure for FY2025 was 0.08%, down 23.0%.
  • Return on Equity for Q4 2025 was 0.06% at Jazz Pharmaceuticals, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Equity for JAZZ hit a ceiling of 0.14% in Q1 2025 and a floor of 0.12% in Q1 2022.
  • Median Return on Equity over the past 5 years was 0.01% (2022), compared with a mean of 0.01%.
  • Biggest five-year swings in Return on Equity: fell -26bps in 2022 and later grew 19bps in 2023.
  • Jazz Pharmaceuticals' Return on Equity stood at 0.08% in 2021, then increased by 12bps to 0.07% in 2022, then soared by 257bps to 0.12% in 2023, then increased by 18bps to 0.14% in 2024, then tumbled by -147bps to 0.06% in 2025.
  • The last three reported values for Return on Equity were 0.06% (Q4 2025), 0.07% (Q3 2025), and 0.08% (Q2 2025) per Business Quant data.